NAZALONE

Welcome to the Brand page for “NAZALONE”, which is offered here for Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; medicinal preparations for use in treatment of opioid overdose and addiction; pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; medicinal preparations for the treatment of substance use disorders, addiction, and overdose; pharmaceutical preparations, opioid antagonists; pharmaceutical preparations, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics;.

Its status is currently believed to be active. Its class is unavailable. “NAZALONE” is believed to be currently owned by “AMPHASTAR PHARMACEUTICALS, INC.”